Pyrronamycin B

Pyrronamycin B has antibacterial activity against Gram-positive and negative bacteria such as Staphylococcus aureus, enterococcus, Escherichia coli, Klebsiella pneumoniae, Proteus, Shigella and Salmonella. Pyrronamycin B also has anti-tumor activity[1].

Product Specifications

CAS Number

[189080-83-9]

UNSPSC

12352211

Target

Bacterial

Related Pathways

Anti-infection

Applications

COVID-19-immunoregulation

Field of Research

Cancer; Infection

Smiles

O=C(C1=CC(NC(CNC(NO)=N)=O)=CN1)NC2=CNC(C(NC(C#N)CC(NC(C=O)C/C=C/CN)=O)=O)=C2

Molecular Formula

C23H29N11O6

Molecular Weight

555.55

References & Citations

[1]A Asai, et al. Pyrronamycin A and B, novel antitumor antibiotics containing pyrrole-amide repeating unit, produced by Streptomyces sp. J Antibiot (Tokyo) . 2000 Jan;53 (1) :66-9.